September 2026 | SCALE
Every owner I hear from frames associate turnover the same way: I can’t compete with what the DSO is paying.
That framing is comfortable, and it is mostly wrong. It turns a structural problem into a checkbook problem, and a checkbook problem has only one solution — pay more — which happens to be the one solution that destroys enterprise value faster than the turnover does.
Let’s start with what we actually know.
What the data says
Becker’s Dental Review, reporting on a TUSK Practice Sales analysis, puts the share of dental students intending to join a DSO-affiliated group at 34%, up from 16% in 2018. Dentists who graduated before 2010 owned practices early at rates of 60–70%. Among 2016–2020 graduates, 21%. Average education debt for the class of 2025: $297,800. Building a competitive new practice: $900,000 to $1.7 million.
DentalPost reports more than a quarter of associate dentists changed employers in 2024, with nearly half actively considering a move.
The usual interpretation is generational: young dentists don’t want to own things. That interpretation explains nothing. It names the pattern and stops. Feynman’s rule applies — knowing the name of something is not the same as understanding it.
So ask the mechanism question instead. What structural feature of a 2026 associate’s financial position makes salaried employment rational?
The mechanism: fixed debt, variable income
Student debt is a fixed obligation. It does not care what your September production looked like. $297,800 at typical repayment terms is a payment that arrives on the same day every month for twenty years.
Associate compensation in an independent practice is almost universally a percentage of collections or adjusted production. That is variable income.
A twenty-eight-year-old with a fixed payment and a variable income is carrying leverage on a volatile asset. The DSO’s offer is not primarily “more dollars.” It is “the same dollars, without the variance.” Salary is a risk-transfer product, and it is being sold to the single population in dentistry least able to absorb risk.
Now layer the ADA Health Policy Institute numbers on top. Through the first half of 2026, reimbursement rose 1.1% against 1.8% inflation. Since January 2021, equipment and supply prices rose 23%, hourly staff wages rose 23%, and reimbursement across all payers rose 19%.
Follow that through to the associate’s bank account. At a constant 30% of collections, if collections per procedure rise 1.1% and the associate’s cost of living rises 1.8%, the associate takes a real pay cut. Nobody decided this. You did not underpay them. The payer repriced them, and your compensation formula passed the repricing straight through.
That is why they are leaving. Not because you are cheap. Because your comp structure hands a young dentist with fixed debt the one thing they cannot hedge.
The arithmetic of a raise
Here is where most retention advice stops being advice and starts being expensive.
Take an associate collecting $700,000 a year. Direct costs attributable to that chair:
| At 30% comp | At 35% comp | |
| Collections | $700,000 | $700,000 |
| Associate compensation | $210,000 | $245,000 |
| Lab (8%) | $56,000 | $56,000 |
| Supplies (6%) | $42,000 | $42,000 |
| Dedicated assistant, fully loaded | $58,000 | $58,000 |
| Contribution | $334,000 | $299,000 |
The raise costs $35,000 of cash this year. That is the number every owner runs.
It is not the decision being made.
If your practice is ever valued on a multiple of earnings — and it will be, whether you sell, bring in a partner, or refinance — call that multiple M. You do not need me to tell you what M is; use whatever number you believe applies to a practice your size. The raise reduces enterprise value by $35,000 × M.
At M = 4, that $35,000 raise is a $140,000 decision. At M = 6, it is a $210,000 decision. And it repeats every year, against a comp base that only ratchets upward.
Now run the other path. Put the same $35,000 in the associate’s pocket by raising what the chair produces, holding the percentage at 30%. Collections have to rise by $35,000 ÷ 0.30 = $116,667.
That increment carries lab and supplies and the comp itself. The assistant is already employed — that cost is fixed.
- Additional collections: $116,667
- Additional comp at 30%: $35,000
- Additional lab and supplies at 14%: $16,333
- Additional contribution: $65,334
Same $35,000 in the associate’s pocket. One path removes $35,000 from earnings. The other adds $65,334. At M = 5, that is $175,000 of enterprise value destroyed versus $326,670 created — roughly a half-million-dollar swing on the same raise.
And I will not pretend the second path is free. $116,667 on a $700,000 base is a 16.7% lift in production per chair-hour. If that associate works roughly 1,472 clinical hours a year, they are producing about $475 per chair-hour today and need to reach about $554. That is real work. It is just work that pays for itself twice.
Three places the lift actually comes from
Delegation you are already legally entitled to. DANB’s Fall 2026 State of the States report, via Becker’s, counted 17 states enacting or implementing changes to dental assistant requirements between April and July 2026 — nine expanded the functions assistants may perform, three modified requirements, three changed supervision levels. Alabama, North Dakota, Florida, Virginia and Iowa are among them. Before you recruit a second doctor to add capacity, read your own state board’s current delegation rules. You may be able to raise production per chair without adding a doctor’s fixed cost at all.
The hygiene program, which is also what your lender is reading. Commerce Bank’s practice-lending guidance is explicit that underwriters look at recall rates and hygiene revenue as a share of collections among the first variables they evaluate, against a debt-service coverage threshold of 1.25x. Set aside the lender for a moment: hygiene is what fills an associate’s schedule. An associate with holes in the book leaves at any compensation percentage, because holes in the book are a pay cut. If the schedule doesn’t work on paper, it will never work in real time.
Payer mix, because you cannot cut your way past a rate you don’t set. Payroll alone runs 30–40% of gross revenue. Expense discipline attacks the controllable slice while the gap sits on the revenue line. Every point of reimbursement you fail to negotiate is a point your associate’s income formula passes straight to them.
There is a fourth move, and it is the cheapest one on this list: compete on variance instead of on level.
A daily-rate guarantee — a floor beneath the percentage, not a replacement for it — costs you only the variance, not the dollars. In a well-scheduled practice the guarantee rarely triggers. You are selling insurance to someone who values it far above what it costs you to provide, because you have a balance sheet and diversified income and they have a fixed payment and one chair. That is the definition of a profitable trade. It is also the exact product the DSO is winning with, and you can underwrite it more cheaply than they can.
Where my own bottom line needs a caveat
In the newsletter I wrote: fix the economics that make your practice worth working in, and you fix the economics that make your practice worth buying.
That is true only if the fix runs through contribution per chair-hour. If the fix runs through the compensation percentage, the two move in opposite directions — the practice gets more attractive to work in and less valuable to own, dollar for dollar, multiplied. Retention purchased with margin is retention you are financing out of your own exit.
Worth saying plainly, since the version of that line without the caveat is the version that sells advisory hours.
The question I’d put to you: Do you have a written growth and partnership runway for your current or next associate — with numbers in it — or are you assuming they will stay long enough for it to matter?
Not making that decision is itself a decision. The circumstances will make it for you, usually on the associate’s timeline rather than yours.
Not sure which decision you’re actually facing?
Stay, Scale, Slow Down, or Sell — most owners are working hard on the wrong one. The What’s Next Assessment is a free, ten-minute tool that sorts which of the four you are genuinely in, before you spend another year optimizing a path you were never on.
Take the What’s Next Assessment →
Dr. David Darab, DDS, MBA, CEPA, practiced oral and maxillofacial surgery for 33 years as a multi-doctor group owner and went through a full private-equity due diligence process before walking away ahead of the LOI. He writes for independent dental practice owners at darabadvisors.com.
The Cash Flow Surgeon™, the 4S Framework™ (Stay, Scale, Slow Down, Sell), and The Decision Before the Decision™ are trademarks of Dr. David Darab and Darab Business Advisors. All rights reserved.